3 days ago
3
Soumya Eswaran
Thu, August 13, 2026 astatine 8:04 AM CDT 3 min read
Alpha Wealth Funds, LLC, an concern absorption company, released its Q2 2026 missive for the "Insiders Fund". A transcript of the missive is disposable to download here. The Fund mislaid 1.45% successful June, portion it was up 8.43% for the 2nd 4th and 0.75% YTD. This compares to the S&P 500's -0.95%, 15.2%, and 9.98% returns, respectively, implicit the aforesaid period. The money underperformed portion the S&P 500 and Nasdaq-100 posted their champion 4th successful six years. A important origin successful this diminution is simply a ~30% attraction successful Alphabet stock, which shifted from a cash-generating plus to a capital-intensive posture pursuing a large banal offering to money information centers. The show of the money was further hampered by losses successful AI semiconductor stocks similar AMD and Intel, which were sold prematurely. The missive concluded with a committedness to hazard absorption portion acknowledging the anticipation of mistakes successful concern strategy. In addition, delight cheque the fund's apical 5 holdings to cognize its champion picks successful 2026.
In its Q2 2026 capitalist letter, Insiders Fund highlighted Insulet Corporation (NASDAQ:PODD). Insulet Corporation (NASDAQ:PODD) is an American aesculapian instrumentality institution known for its Omnipod platform, an insulin transportation strategy for radical with insulin-dependent diabetes. On August 12, 2026, Insulet Corporation (NASDAQ:PODD) closed astatine $161.28 per share. The one-month instrumentality of Insulet Corporation (NASDAQ:PODD) was -11.78%, and its shares mislaid 54.06% implicit the past 52 weeks. Insulet Corporation (NASDAQ:PODD) has a marketplace capitalization of $11.17 billion.
Insiders Fund stated the pursuing regarding Insulet Corporation (NASDAQ:PODD) successful its Q2 2026 capitalist letter:
"Business: Insulet Corporation (NASDAQ:PODD) is simply a person successful aesculapian technology, chiefly known for its Omnipod Insulin Management System. Unlike accepted insulin pumps that necessitate integrative tubing, the Omnipod is simply a wearable, waterproof "pod" that delivers insulin continuously. Insider Buying/Selling: Ashley McEvoy (President & CEO): Purchased 4,300 shares astir February 20–25, 2026, astatine an mean terms of $239.35 per share, representing an concern of conscionable implicit $1 million. ● Michael R. Minogue (Independent Director): Purchased 2,030 shares connected February 26, 2026, astatine an mean terms of $246.23 per share, totaling astir $499,800. Elizabeth Weatherman (Independent Chair): Most recently, successful aboriginal June 2026, she purchased astir $497,000 worthy of banal astatine a little terms constituent of $144 per share, which boosted her full holdings by 66%.
Recent News: Insulet's (PODD) stock terms is presently caught successful a tug-of-war betwixt beardown cardinal fiscal maturation and escalating manufacturing and ineligible headwinds. Late May Correction: On May 26, 2026, Insulet had to initiate different voluntary aesculapian instrumentality correction for circumstantial tons of Omnipod 5, Dash, and Eros pods owed to a cannula (tubing) teardrop that could pb to unsafe insulin under-delivery. This sent the banal terms tumbling implicit 5% down to ~$146..." (Click present to work the afloat text)
English (CA) · 
English (US) · 
Spanish (MX) ·